Lucid Pharma Private Limited - Company Profile

It is a agriculture private limited company based in Mumbai, Maharashtra, India, established in 2003.
2003 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Lucid Pharma Private Limited

Lucid Pharma Private Limited, a active private limited company, was established on 04 November 2003 in Mumbai, Maharashtra, India. Engaging in horticulture & produce within the agriculture, forestry, fishing sector, it holds CIN: U01400MH2003PTC142980. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.55 Cr and a paid-up capital of ₹2.10 Cr.

It upholds a compliant status. Its leadership includes Kewal Chand Dakalia (Director), Ummed Singh (Additional Director), Vikram Singh Rathore (Director). Past directors included Amit Chintaman Patil, Naunand Kanwar, Gajendra Singh Sekhawat. It holds no open charges and ₹9.20 Cr settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 111, Mumbai Market Building Near Ac Market, Tardeo, Mumbai, Maharashtra, 400034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U01400MH2003PTC142980

  • Registration Number

    142980

  • Incorporation Date

    04 November 2003

  • Authorized Capital

    ₹2.55 Cr

  • Paid-Up Capital

    ₹2.10 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.55 Cr
  • Paid Up Capital ₹ 2.10 Cr
  • Company Age 22 Year, 3 Months
  • Last Filing with ROC 31 Mar 2018
  • Satisfied Charges ₹ 9.20 Cr
  • Revenue Growth **** %
  • Profit Growth **** 1129.48%
  • Ebitda **** 25.65%
  • Net Worth 1.77%
  • Total Assets -1.80%
Company report

Lucid Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lucid Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Lucid Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kewal Chand Dakalia Director 06 Mar 2014 Current
Ummed Singh Additional Director 25 Apr 2019 Current
Vikram Singh Rathore Director 01 Sep 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2011 Past
Pramod Abcsdd Director 01 Nov 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2012 Past
Pramod Abcsdd Director 31 Oct 2019 Past
Pramod Abcsdd Director 01 Nov 2011 Past
Pramod Abcsdd Director 10 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lucid Pharma.

Lucid Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1129.48% increase in profit. The company's net worth moved up by a moderate rise of 1.77%.

Lucid Pharma revenue growth over time
Lucid Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -1.80%
*******
*******
*******
*******
Profit or Loss
*******
 1129.48%
*******
*******
*******
*******
Net Worth
*******
 1.77%
*******
*******
*******
*******
EBITDA
*******
 25.65%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lucid Pharma?

In 2018, Lucid Pharma had a promoter holding of 36.76% and a public holding of 63.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹92,000,000.00

Charges Breakdown by Lending Institutions
  • Bank Of Maharashtra : 9.20 Cr
Latest Charge Details
Date Lender Amount Status
26 Dec 2005 Bank Of Maharashtra ₹4.60 Cr Satisfied
21 Dec 2005 Bank Of Maharashtra ₹4.60 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lucid Pharma?

Unlock and access historical data on people associated with Lucid Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lucid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucid Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lucid Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Ummed Singh was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2019 & has been associated with this company since 6 years 9 months . was completed.

  • Annual General Meeting

    Progress on Lucid Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Lucid Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Vikram Singh Rathore was appointed as a Director was appointed as a Director on 01 Sep 2014 & has been associated with this company since 11 years 5 months . was completed.

  • Director Appointment

    Progress on Kewal Chand Dakalia was appointed as a Director was appointed as a Director on 06 Mar 2014 & has been associated with this company since 11 years 11 months . was documented.

  • Charges

    Progress on A charge registered on 26 Dec 2005 via Charge ID 80006963 with Bank Of Maharashtra was fully satisfied on 26 Aug 2008. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lucid Pharma Private Limited?

The CIN of Lucid Pharma Private Limited is U01400MH2003PTC142980.

Where is Lucid Pharma Private Limited headquartered?

Lucid Pharma Private Limited is headquartered at 111, Mumbai Market Building Near Ac Market, Tardeo, Mumbai, Maharashtra, 400034.

When was Lucid Pharma Private Limited incorporated?

Lucid Pharma Private Limited was incorporated on 04 November 2003.

Who are the current directors of Lucid Pharma Private Limited?

The current directors of Lucid Pharma Private Limited are

What is the primary industry of Lucid Pharma Private Limited?

The primary industry of Lucid Pharma Private Limited is Agriculture, Forestry, Fishing.

Is Lucid Pharma Private Limited a listed company?

Lucid Pharma Private Limited is unlisted.

What is the capital structure of Lucid Pharma Private Limited?

The authorized capital of Lucid Pharma Private Limited is ₹2.55 Cr, and the paid-up capital is ₹2.10 Cr.

What is the compliance status of Lucid Pharma Private Limited?

The compliance status of Lucid Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available